SONN

Sonnet BioTherapeutics
SONN

Delisted

SONN was delisted on the 2nd of December, 2025.

Back to rankings

hedge funds and large institutions have $433K invested in Sonnet BioTherapeutics in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less capital invested

Capital invested by funds: $ → $
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$16K
2
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$90K
2
$54K
3
$52K
4
$43K
5
$37K
6
$25K
7
$19K
8
$18K
9
$17K
10
$12K
11
$11K
12
$10K
13
$8K
14
$7K
15
$7K
16
$6K
17
$5K
18
$4K
19
$3K
20
$2K
21
$1K
22
$1K
23
$1K
24
–
25
–